News | News By Subject | News by Disease News By Date | Search News

Hypercholesterolemia (high blood cholesterol) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Regeneron (REGN), Sanofi (SNY)'s Potential Blockbuster Praluent Passes Late-Stage Test     8/30/2016
Amgen (AMGN) Responds to 'Flawed' Cholesterol Study     8/23/2016
Esperion (ESPR) Falls on Lack of FDA Clarity for Cholesterol Drug     6/29/2016
Catabasis (CATB) Craters as Cholesterol Drug Flunks Mid-Stage Study     6/8/2016
Amgen (AMGN) Researchers Discover Gene that Cuts Heart Attack Risk     5/23/2016
Regeneron (REGN) CEO Says Critique of the Company's New Cholesterol Lowering Therapy Was Non-Scientific     5/13/2016
3 Biotechs Getting Another Shot After Failed Trials     4/7/2016
Data Behind Eli Lilly (LLY)'s Decision to Halt Potential Cholesterol Blockbuster Released Last Weekend     4/5/2016
Pfizer (PFE)'s Bococizumab Met Primary Endpoints in Phase III Trial     4/1/2016
Amgen (AMGN) to Present 19 Abstracts at American College of Cardiology     3/22/2016
Amgen (AMGN) Wins Trial Against Regeneron (REGN) and Sanofi (SNY) for Cholesterol Drug Patents, Appeal Likely     3/18/2016
Amgen (AMGN)'s Repatha Met Co-Primary Endpoints in Phase III GAUSS-3 Study     2/5/2016
Regeneron (REGN) Investors Get Jitters From False Praluent Data     1/8/2016
CVS Picks Amgen (AMGN)'s Repatha Over Sanofi (SNY)-Regeneron (REGN)'s Cholesterol Drug     11/23/2015
A Look Into Merck & Co. (MRK)'s Half a Billion Dollar Cholesterol Program and Whether It's Paid Off     11/20/2015

News from Around the Web
Cholesterol Drug Shows Promise To Help Reverse Heart Disease     11/16/2016
These Pricey Cholesterol Drugs Aren't Selling. And That Has The Biotech Industry Sweating     10/28/2016
Testing Cholesterol In Toddlers, Even Younger? Queen Mary University Of London Study Says It Could Help     10/27/2016
In This War Over Statins, How Can Patients Win?     10/11/2016
A $14,000 Price Tag For A Cholesterol Drug Can Be A Bargain     9/6/2016
Barley Lowers Not One But Two Types Of 'Bad Cholesterol,' St. Michael's Hospital Study Suggests     6/8/2016
Some People Really Can't Take Statins For High Cholesterol, Cleveland Clinic Scientists Reveal     4/5/2016
The Benefits Of Walnuts On Age-Related Health Issues Investigated, Loma Linda University Reveals     4/4/2016
Young Hispanic Pot Smokers Have Lower Odds Of Metabolic Syndrome, University of Miami Study Finds     3/17/2016
No Link Found Between Insomnia And Cholesterol Levels, St. Michael's Hospital Study Reveals     3/3/2016
Metabolic Syndrome Tied To Cognitive Impairment Risk, National University of Singapore (NUS) Study     3/1/2016
New Vaccine Could Prevent High Cholesterol, University of New Mexico Study     11/11/2015
Eli Lilly (LLY)’s Pain Is A Success For These Companies     10/19/2015
Grip Strength May Reveal Whether You Have Diabetes, High BP, University of Florida Study     8/7/2015
Do Cholesterol Drugs Affect Aggression? University of California, San Diego (UCSD) Study     7/2/2015

Press Releases
No Early Success for Regeneron (REGN) and Sanofi (SNY)'s Cholesterol Drug Praluent     11/17/2016
Viking Therapeutics (VKTX) Presents New Clinical Data On VK2809 In Subjects With Elevated Cholesterol At AHA Scientific Sessions 2016     11/15/2016
Ionis Pharma (IONS) Reports Positive Clinical Data From IONIS-ANGPTL3-L Rx     11/15/2016
Viking Therapeutics (VKTX) Doses First Patient In Phase 2 Clinical Trial Of VK2809 In Patients With Hypercholesterolemia And Non-Alcoholic Fatty Liver Disease     10/4/2016
Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data     9/15/2016
Amgen (AMGN) Release: New Repatha (evolocumab) Analyses Show Efficacy And Safety Across Risk Groups In Results Presented At European Society of Cardiology Congress 2016     8/29/2016
Amgen (AMGN) Reports Second Quarter 2016 Financial Results     7/28/2016
Apotex Launches Rosuvastatin Calcium Tablets Generic Version Of AstraZeneca PLC (AZN)'s Crestor     7/22/2016
Amgen (AMGN) Release: FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor     7/11/2016
Mylan (MYL) Launches Generic Fenoglide Tablets     7/6/2016
Regeneron (REGN) And Sanofi (SNY) Announce Approval Of Praluent (Alirocumab) For The Treatment Of Hypercholesterolemia In Japan     7/5/2016
Regeneron (REGN) Presents Positive Interim Data From Phase 2 Proof-Of-Concept Study Of Evinacumab In Patients With Homozygous Familial Hypercholesterolemia     5/31/2016
Catabasis Pharma To Present Pre-Clinical Data Supporting CAT-2054 As A Potential Treatment For Nonalcoholic Steatohepatitis (NASH) At Digestive Disease Week 2016     5/16/2016
Viking Therapeutics (VKTX) Reports First Quarter 2016 Financial Results And Provides Corporate Update     5/11/2016
ANI Pharma Announces Launch Of 50mg And 150mg Fenofibrate Capsules In ANI Label     5/9/2016

//-->